J. Anthony Ware, Director at First Tracks Biotherapeutics, Inc. (TRAX), sold 39,265 shares at $44.78 ($1.8M) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Open-market sale of $1.8M TRAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |